RELMADA THERAPEUTICS INC COM
RLMD·75955J402·US·Common Stock·Healthcare - Biotechnology-13D/G
RLMD (RELMADA THERAPEUTICS INC COM) is held by 67 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($51.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($33M), VANGUARD CAPITAL MANAGEMENT LLC ($30.9M). Net institutional sentiment: Mixed.
67
Holders
(2 Elite)
$299.1M
Total Value
66% (77)
Consensus
51 buying - 26 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Sep 11, 2026 · Activists Aug 14, 2026 · Congress none
InsiderSMShenouda MagedBuy $339KSep 10, 2026
InsiderTSTRAVERSA SERGIOBuy $410KSep 10, 2026
InsiderSMShenouda MagedBuy $505KSep 9, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 82
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
415 holders · $877.5B
415 holders · $299.1B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer